🇺🇸 FDA
Patent

US 10080799

Methods and compositions related to glycoprotein-immunoglobulin fusions

granted A61KA61K2039/55566A61K38/00

Quick answer

US patent 10080799 (Methods and compositions related to glycoprotein-immunoglobulin fusions) held by ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY expires Mon Sep 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY
Grant date
Tue Sep 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K2039/55566, A61K38/00, A61K39/12, A61K39/29